Trials / Completed
CompletedNCT03231774
Comparability of Hemodynamic Parameters Measured by Non-invasive Echocardiography and by Right Heart Catheterization
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Heart and Diabetes Center North-Rhine Westfalia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to compare transthoracic Echocardiography TTE to the gold standard Right Heart Catheterization in Terms of accuracy to measure hemodynamic parameters.
Detailed description
Chronic heart failure is a progressive disease in Western population. Echocardiography and right heart catheterization are important tools in the diagnosis and progress monitoring of heart failure. Gold standard in diagnosis of hemodynamic parameters in patients with heart failure is right heart catheterization. However, this diagnostic device represents an invasive method that is additionally associated with high risks such as infections, vessel and nerve injuries. Echocardiography is probably in a position to determine hemodynamic parameters as reliably as right heart catheterization without additional health risk due to its non-invasive character. All procedures performed are part of clinical Routine. Patients do not undergo any study-specific procedure at all.
Conditions
Timeline
- Start date
- 2017-07-21
- Primary completion
- 2017-12-31
- Completion
- 2018-07-31
- First posted
- 2017-07-27
- Last updated
- 2020-10-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03231774. Inclusion in this directory is not an endorsement.